Senior insider sale
Chief Legal Officer at DEFINIUM THERAPEUTICS, INC. — senior position signals high conviction
$188.4K
22.77K shares
What this filing means
SULLIVAN MARK plans to sell 22.77K shares of DEFINIUM THERAPEUTICS, INC. valued at approximately $188.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/25/2025ACC: 0001950047-25-007518
Officer· Chief Legal Officer
Since Feb 2026
22.77K
Shares to sell
$188.4K
Approx. market value
11.28K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Compensation
9/25/2025
11.28KTotal acquired11.28K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/25/2025 | Restricted stock vesting under a registered plan Compensation | 11.28K | — |
| Total | 11.28K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
11.49K
Market value
$78.2K
6/25/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
11.28K
Market value
$110.2K
9/25/2025
Total
Units
22.77K
Value
$188.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/25/2025 | 11.49K | $78.2K | — | Completed |
| Planned — Approximate Date | ||||
9/25/2025 | 11.28K | $110.2K | NASDAQ | Planned |
| Total | 22.77K | $188.4K | ||